Human microbiota derived N-acyl amides for the treatment of human disease
- 专利权人:
- The Rockefeller University
- 发明人:
- Louis Cohen,Sean Brady
- 申请号：
- US16627440
- 公开号：
- US20200113950A1
- 申请日:
- 2018.06.29
- 申请国别(地区):
- US
- 年份:
- 2020
- 代理人:
- 摘要：
- The present invention provides compositions and methods for the modulation of G protein-coupled receptors (GPCRs).
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Method for using the control of the vegetative bacteria disease of carboxamide derivatives
- ナトリウムチャネルモジュレーターとしてのプロリンアミド誘導体
- Compounds derived from 2 - aminoquinazolina replaced； Pharmaceutical composition that is useful for the treatment of a disorder involving Modulation of TLR7 / TLR8 as Viral Infections.
- Compounds derived from 2 - (amino acid 3heteroaril - 1,2,3,4 - tetrahydro - 9h carbazole farnaceutica) - acetic acid, the composition comprises, and their use as Medicines,In the prophylaxis and / or treatment of diseases mediated by the Modulation of prostaglandin D2 Like Receptors, immune or allergic disorders.
- Composition for controlling plant diseases, which comprises a carboxamide derivative fludioxonil And Compound； and a method for controlling plant diseases, which comprises treating a plant orThe Soil where it grows a plant with an effective amount of the composition for controlling Phyto diseases.
